Originally a focus of research in neurodegenerative diseases like Alzheimer’s Disease with a potential beneficial role, triggering receptor expressed on myeloid cells 2 (Trem2) in glioma is believed to be widely expressed by disease-associated, inflammatory microglia. The gene discussed is TREM2; the disease is central nervous system cancer.